CROSSBETA STABLE Aβ OLIGOMERS: DISEASE-RELEVANT DRUG TARGETS AND VERSATILE REFERENCE STANDARDS IN BIOMARKER ASSAYS IN AD

Autor: Apetri, Mihaela, Tepper, Armand W.J.W., Sr., Hoogveld, Emily, Vis, Joost D.J., de Boer, Marco, Scheefhals, Guus A.P.H.

Publikováno v: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2017 13(7) Supplement:P355-P356

Novel approach for the identification of small drug-like molecules that neutralize beta-amyloid 1-42 toxicity through direct interaction with oligomers

Autor: Tepper, Armand, de Boer, Liesbeth, Hoogveld, Emily, Scheefhals, Guus, Gebbink, Martijn

Publikováno v: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2013 9(4) Supplement:P327-P327

AAV mediated gene therapy as local treatment modality directed against amyloid beta oligomers in the brain using a high affinity, high specificity antibody: Nonhuman: Preclinical immunotherapeutic studies.

Autor: Blits, Bas, Gouwenberg, Yvonne, Gebuis, Titia, van der Loo, Rolinka, van Kesteren, Ronald E., Smit, August B., Preusting, Hans, Scheefhals, Guus

Publikováno v: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2020 Supplement S11, Vol. 16 Issue 11, p1-1, 1p

Aβ oligomers as tractable drug targets in Alzheimer's disease: in vivo proof of concept for the oligomer-binding small-molecule therapeutic candidate cbb68.

Autor: Tepper, Armand W.J.W., de Boer, Elizabeth C., Hoogveld, Emily, Vis, Joost D.J., Schut, Ivar C., Vereyken, Ingrid J., Hoffmann, Marcel, Scheefhals, Guus A.P.H.

Publikováno v: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jul2015 Supplement, Vol. 11 Issue 7, pP841-P842, 1p